40 likes | 51 Views
Biomarkers Market Size Overview by Industry Trends, Share, Growth Factor and Analysis to 2026
E N D
The global “biomarkers” market is set to gain traction from their increasing usage in a wide variety of applications, namely, drug discovery and development, safety assessment, and medicine. Besides, numerous biotech and pharmaceutical companies are persistently investing huge sums in the research and development activities. The increasing prevalence of cancer is also one of the crucial factors that would affect the market positively during the forecastperiod. • The above information is given by Fortune Business Insights™ in a recent study, titled, “Biomarkers Market Size, Share & Industry Analysis, By Indication (Oncology, Cardiology, Neurology, and Others), By End User (Pharmaceutical & Biotechnology Companies, Diagnostics & Research Laboratories, Hospitals & Specialty Clinics, and Others), and Regional Forecast, 2019-2026.” The study further mentions that the biomarker market size was USD 39.10 billion in 2018 and is projected to reach USD 97.51 billion by 2026, thereby exhibiting a CAGR of 12.1% during the forecastperiod. • Request a Sample Copy of the ResearchReport: • https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/biomarkers-market-102173 • Key Players Operating in The BiomarkersMarketInclude: • Key players are involved in mergers and acquisition to strengthen their market position. Owing to increasing competition frequent innovations are taking place in the market. Some of the companies operating the industry are: • Abbott • R&DSystem • F. Hoffmann-La Roche Ltd. • R&DSystem • Thermo Fisher Scientific • AxonMedchem • Bio-Rad Laboratories, Inc. • BioVisionInc. • Sino BiologicalInc. • CENTOGENE N.V. • Other key marketplayers • Highlights of theReport: • In-depth analysis of various insights, namely, Biomarkers Markettrends, growth drivers, opportunities, and other relatedchallenges. • Comprehensive details of key market players, their core competencies, and BiomarkersMarketshare. • The potency of suppliers and buyers to make better businessdecisions. • Lists out the market size in terms ofvolume. • Increasing Demand for Personalized Medicine to AccelerateGrowth • Biomarkers are increasingly used in disease diagnostics. They also play an important role in development of personalized medicine for several disease conditions. Disease diagnosis and treatment procedures possess certain limitations and because of this, the concept of personalized medicine is becoming popular nowadays. Patients suffering from immunological disorders and cancer are rapidly inclining towards customized treatment options based on their genetic and clinical features. It would propel the biomarkers market growth during the forecastperiod. • For more information in the analysis of this report, visit: • https://www.fortunebusinessinsights.com/biomarkers-market-102173
Oncology Segment to Grow Steadily Backed by Rising Prevalence of ChronicDiseases • In terms of indication, the market is grouped into oncology, cardiology, neurology and others. Out of these, the oncology segment dominated the market in 2018. This growth is attributable to the increasing cases of cancer. Growing demand for personalized medicine in diagnosis and treatment of cancer, along with increasing number of new biomarker based assays and tests being introduced by market players, is propelling the growth of oncology segment. Rising prevalence of neurological disorders and increasing investment by key market players in the development of neurology biomarkers are is one of the major factor anticipated to drive the growth of the segment at faster rate. • Detailed Table ofContent: • Introduction • ResearchScope • MarketSegmentation • ResearchMethodology • Definitions and Assumptions • ExecutiveSummary • MarketDynamics • MarketDrivers • MarketRestraints • MarketOpportunities • Key Insights • New Product Launches, by Key Market Players • Prevalence by Disease Indication, By Key Countries/ Region,2018 • Incidence of Cancer, By Key Countries/ KeyRegion,2018 • Key industry Developments - Mergers, Acquisitions andPartnerships • Overview of Biomarkers In PersonalizedMedicine • Global Biomarkers Market Analysis, Insights and Forecast,2015-2026 • Key Findings / Summary • Market Analysis, Insights and Forecast – ByIndication • Oncology • Cardiology • Neurology • Others • Market Analysis, Insights and Forecast – By EndUser • Pharmaceutical & BiotechnologyCompanies • Diagnostics & ResearchLaboratories • Hospitals & SpecialtyClinics • Others • Market Analysis, Insights and Forecast – ByRegion • NorthAmerica • Europe • Asia Pacific • LatinAmerica • Middle East & Africa • Have Any Query? Ask Our Experts: https://www.fortunebusinessinsights.com/enquiry/speak-to- analyst/biomarkers-market-102173 • ReportFocus: • Extensive productofferings • Customer researchservices
Robust researchmethodology • Comprehensive reports • Latest technological developments • Value chain analysis • Potential BiomarkersMarketopportunities • Growthdynamics • Qualityassurance • Post-salessupport • Regular reportupdates • Reasons to Purchase this Report: • Comprehensive analysis of the Biomarkers Marketgrowth drivers, obstacles, opportunities, and other relatedchallenges. • Tracks the developments, such as new product launches, agreements, mergers and acquisitions, geographical expansions, and jointventures. • Identifies market restraints andboosters. • Identifies all the possible segments present in the market to aid organizations in strategic business planning. • KEY QUESTIONSANSWERED: • What is the market size and growth rate of the global and regional market by varioussegments? • What is the market size and growth rate of the market for selectivecountries? • Which region or sub-segment is expected to drive the market in the forecastperiod? • What Factors are estimated to drive and restrain the BiomarkersMarketgrowth? • What are the key technological and market trends shaping themarket? • What are the key opportunities in themarket? • What are the key companies operating in themarket? • Which company accounted for the highest marketshare? • AboutUs: • Fortune Business Insights™ offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them to address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operatingin. • Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our team of experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies, interspersed with relevantdata. • At Fortune Business Insights™ we aim at highlighting the most lucrative growth opportunities for our clients. We, therefore, offer recommendations, making it easier for them to navigate through technological and market-related changes. Our consulting services are designed to help organizations identify hidden opportunities and understand prevailing competitivechallenges. • ContactUs: • Fortune Business Insights™ Pvt. Ltd. 308, Supreme Headquarters, Survey No. 36,Baner, • Pune-Bangalore Highway, • Pune - 411045, Maharashtra, India. • Phone: • US :+1 424 2530390
UK : +44 2071 939123 APAC : +91 744 7401245 Email: sales@fortunebusinessinsights.com Linkedin| Twitter|BLogs